18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma.

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Head and neck squamous cell carcinoma (HNSCC) represents the eighth most common malignancy worldwide. Standard-of-care treatments for patients with HNSCC include surgery, radiation, and chemotherapy. In addition, the anti-EGFR monoclonal antibody cetuximab is often used in combination with these treatment modalities. Despite clinical success with these therapeutics, HNSCC remains a difficult malignancy to treat. Thus, identification of new molecular targets is critical.

          Related collections

          Author and article information

          Journal
          Clin. Cancer Res.
          Clinical cancer research : an official journal of the American Association for Cancer Research
          1078-0432
          1078-0432
          Jun 1 2015
          : 21
          : 11
          Affiliations
          [1 ] Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
          [2 ] Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin. Department of Medical Physics, University of Wisconsin, Madison, Wisconsin.
          [3 ] Department of Medical Physics, University of Wisconsin, Madison, Wisconsin.
          [4 ] Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, Wisconsin.
          [5 ] Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin.
          [6 ] Departments of Medicine and Pathology, University of Southern California, Los Angeles, California.
          [7 ] Department of Pathology, University of Chicago Medical Center, Chicago, Illinois.
          [8 ] Division of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.
          [9 ] Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin. dlwheeler@wisc.edu.
          Article
          1078-0432.CCR-14-2648 NIHMS809134
          10.1158/1078-0432.CCR-14-2648
          5032632
          25767293
          fe73766f-57ad-4e95-94be-30385a24804b
          ©2015 American Association for Cancer Research.
          History

          Comments

          Comment on this article